By contrast, the presence of high CD4+ and low CD8+ tumor-infiltrating lymphocyte levels were independent predictors of poor progression-free survival (PFS), while the former was positively correlated with late tumor stage (52). This evidence concerns the gene CD8A and neoplasm.